Drugs / OCDC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01132014 | May 2010 → May 2018 | ovarian cancer | Abramson Cancer Center at Penn Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OCDC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01132014 ↗ |
| Modality | Vaccine | “autologous vaccine” NCT01132014 ↗ |
| Route | Other | “administered intranodally” NCT01132014 ↗ |